Next Article in Journal
Development and Validation of an UPLC-MS/MS Method for Pharmacokinetic Comparison of Five Alkaloids from JinQi Jiangtang Tablets and Its Monarch Drug Coptidis Rhizoma
Next Article in Special Issue
Development of a Region-Specific Physiologically Based Pharmacokinetic Brain Model to Assess Hippocampus and Frontal Cortex Pharmacokinetics
Previous Article in Journal
GE11 Peptide as an Active Targeting Agent in Antitumor Therapy: A Minireview
Previous Article in Special Issue
Prediction of Drug-Drug Interactions with Bupropion and Its Metabolites as CYP2D6 Inhibitors Using a Physiologically-Based Pharmacokinetic Model
 
 
Article

Article Versions Notes

Pharmaceutics 2018, 10(1), 3; https://doi.org/10.3390/pharmaceutics10010003
Action Date Notes Link
article pdf uploaded. 29 December 2017 07:06 CET Version of Record https://www.mdpi.com/1999-4923/10/1/3/pdf-vor
article xml uploaded. 29 December 2017 07:06 CET Original file -
article html file updated 29 December 2017 07:07 CET Original file -
article pdf uploaded. 5 January 2018 07:56 CET Updated version of record https://www.mdpi.com/1999-4923/10/1/3/pdf
article xml uploaded. 5 January 2018 07:56 CET Update https://www.mdpi.com/1999-4923/10/1/3/xml
article html file updated 5 January 2018 07:57 CET Update -
article html file updated 27 March 2018 14:51 CEST Update -
article html file updated 28 March 2019 11:49 CET Update -
article html file updated 18 April 2019 03:34 CEST Update -
article html file updated 2 May 2019 05:33 CEST Update -
article html file updated 29 September 2019 13:14 CEST Update -
article html file updated 9 February 2020 01:28 CET Update https://www.mdpi.com/1999-4923/10/1/3/html
Back to TopTop